Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study

Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study

BackgroundGraves' orbitopathy (GO) occurs in approximately 25-40% of patients with Graves' disease (GD). High levels of anti-thyrotropin receptor antibodies (TRAbs), smoking habit, sex, older age, longer duration and amount of hyperthyroidism or hypothyroidism are well-recognized risk fact...

Full description

Bibliographic Details
Main Authors: Rosario Le Moli, Adriano Naselli, Gabriele Costanzo, Tommaso Piticchio, Dario Tumino, Gabriella Pellegriti, Francesco Frasca, Antonino Belfiore
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-07-01
Series:Frontiers in Endocrinology
Subjects:
parenteral glucocorticoids
oxidative stress
Graves' orbitopathy phenotype
LDL - cholesterol
hypertension
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1401155/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1401155/full

Similar Items